Novel vectors and approaches for gene therapy in liver diseases

Gene therapy is becoming an increasingly valuable tool to treat many genetic diseases with no or limited treatment options. This is the case for hundreds of monogenic metabolic disorders of hepatic origin, for which liver transplantation remains the only cure. Furthermore, the liver contains 10–15%...

Descripción completa

Detalles Bibliográficos
Autores principales: Maestro, Sheila, Weber, Nicholas D., Zabaleta, Nerea, Aldabe, Rafael, Gonzalez-Aseguinolaza, Gloria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203845/
https://www.ncbi.nlm.nih.gov/pubmed/34159305
http://dx.doi.org/10.1016/j.jhepr.2021.100300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203845/
https://www.ncbi.nlm.nih.gov/pubmed/34159305
http://dx.doi.org/10.1016/j.jhepr.2021.100300

Ejemplares similares